Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

653
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
653
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

433
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

698
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
698

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bleeding-related quality of life in older adults: Psychometric evaluation of the HEmorrhage Life Impact indeX (HELIX).

Thrombosis research·2026
Same author

The Burden of Cardiovascular Disease in Older Adults.

Clinics in geriatric medicine·2026
Same author

Changes in arterial stiffness under blood pressure control are independently associated with cognitive impairment: The Systolic Blood Pressure Intervention Trial (SPRINT).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Same Patients, Different Health Care Systems-Revisited. Geriatric Care Models in the U.S., Canada, and Europe.

Journal of the American Geriatrics Society·2026
Same author

Targeted Nrf2 activation improves vascular endothelial function with aging and prevents vascular dysfunction following disuse in younger and older adults.

Free radical biology & medicine·2026
Same author

Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial.

JACC. Advances·2026
Same journal

The PROMISE-ACHD Score: Prediction of Perioperative Mortality and Major Morbidity in Adult Congenital Heart Disease.

JACC. Advances·2026
Same journal

Antenatal Care as a Strategic Window for Long-Term Cardiovascular Risk Assessment.

JACC. Advances·2026
Same journal

Achieving Equity in Generative Artificial Intelligence in Cardiovascular Medicine.

JACC. Advances·2026
Same journal

Real-World Experience With a Novel Intravascular Hertz Contact Lithotripsy Balloon in Severely Calcified Coronary Lesions.

JACC. Advances·2026
Same journal

Trends in Cardiac Arrest Mortality Among Young Adults in the United States, 1999 to 2024.

JACC. Advances·2026
Same journal

Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).

JACC. Advances·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K

Hypertension in the Oldest Old.

Mark A Supiano1, Simon B Ascher2, Michael W Rich3

  • 1Spencer Fox Eccles School of Medicine and University of Utah Center on Aging, Salt Lake City, Utah, USA.

JACC. Advances
|November 13, 2025
PubMed
Summary
This summary is machine-generated.

Hypertension is common in adults aged 80 and older, increasing risks for serious health issues. This review proposes the geriatrics 4 Ms model for individualized hypertension management in the oldest adults.

Keywords:
deprescribinggeriatrics 4 Ms modelhypertensionoldest old

More Related Videos

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Related Experiment Videos

Last Updated: Jan 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Area of Science:

  • Geriatric Medicine
  • Cardiovascular Research
  • Public Health

Background:

  • Hypertension is highly prevalent in adults aged 80+, significantly contributing to cardiovascular disease, stroke, kidney disease, and cognitive impairment.
  • Antihypertensive therapy offers benefits for major cardiovascular events and cognitive decline in this demographic.
  • Clinical trials have historically excluded many oldest old patients due to frailty, cognitive issues, comorbidities, or nursing home residency.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, diagnosis, and management of hypertension in adults aged 80 years and older.
  • To introduce the geriatrics 4 Ms model as a patient-centered care framework for this population.
  • To highlight the need for further research in underrepresented groups and the role of deprescribing.

Main Methods:

  • Literature review of hypertension in the oldest old (≥80 years).
  • Analysis of epidemiological data and pathophysiology.
  • Discussion of diagnostic and management strategies, including the proposed 4 Ms model.

Main Results:

  • Hypertension is a critical risk factor for morbidity and mortality in the oldest old.
  • Existing evidence supports antihypertensive therapy but highlights exclusion of vulnerable subgroups from trials.
  • The geriatrics 4 Ms model offers a structured approach to individualized care.

Conclusions:

  • Individualized, patient-centered care is essential for managing hypertension in the oldest old.
  • The geriatrics 4 Ms model provides a framework for addressing the complexities of hypertension in this population.
  • Further research is crucial, particularly focusing on underrepresented patients and deprescribing strategies.